The Sample Before Sydney: Peres Jepchirchir's EPO Case and the Interval Nobody Files

30 August 2026, Sydney. Peres Jepchirchir ran two hours, 18 minutes and 31 seconds. The margin over her compatriot Irene Chepet Cheptai was more than three minutes. The Sydney Marathon had become the seventh World Marathon Major in 2026, and that afternoon its start list began with the biggest name it could buy.

Then the notice came from the Athletics Integrity Unit. Provisional suspension. The reason: an out-of-competition sample positive for EPO, erythropoietin. And the one sentence that supplies the architecture of the whole story — the sample was provided in Kenya, before the race.

There are two dates here. The one on the sample, and the one on the notice. The interval between them is my subject. What is written has been read. What is not written is what I am reading now.

What follows is not an accusation. It is a paper trail, read in order.

First, the ledger that is clean

Jepchirchir is 33. Her record needs dates, not adjectives. She set the women's half-marathon world record in 2026 and broke it three times in 2026. She won the women's marathon at the Tokyo 2026 Olympics, returned to the same city in September 2026 to win the World Championships, and took New York in 2026, Boston in 2026 and London in 2026.

I am printing that list for a reason other than effect. Every time a provisional suspension lands, the athlete's career is split into two halves on social media — the clean part and the stained part. Documents do not split careers that way. A document prints a date and then asks questions around it. The rest is our habit.

One thing the record shows and few people join up: Sydney was her first major title after becoming world champion. Between September 2026 and August 2026 she held a world title and no new major. For a marathon runner that is the block in which the longest, quietest, highest-mileage work gets done.

EPO: a short window, a large stake

EPO is a natural substance produced in the kidneys that stimulates the creation of new red blood cells. Injected, it is detectable in urine or blood only for a short window, and it raises the number of red blood cells carrying oxygen to the muscles. The effect is direct, and over 42 kilometres it is the difference every marathon runner can feel and none can manufacture.

Here is the fact that goes missing from most doping arguments. EPO gets caught. It gets caught only inside the window in which a sample is taken. The question, then, is never about the substance. It is about the calendar. The day the sample was collected was a decision made by a testing agency, not by an athlete.

Two things therefore have to be kept apart in this case. The first is that EPO was found — that is a laboratory result, and the B sample and a hearing are still outstanding. A provisional suspension is not a finding; it is the first document in a process. The second is when and where the sample was taken — that is a testing plan, and the argument about it belongs to the system that chose the sample, not to the athlete alone.

What the notice does not say

An AIU provisional suspension notice is a short document. It gives a date, a location, a substance, and the fact of immediate suspension.

It does not give the concentration of EPO in the sample. It does not give the date the laboratory returned the result. It does not give the date the athlete was informed. It does not say whether this was a planned test or a random one, or which whereabouts cycle the collection fell under.

None of those blanks are evidence of a cover-up. They are blanks that sit in every provisional suspension notice, and filling them takes months — usually with the kind of final, unglamorous clarity that no outlet has the appetite to cover. My habit is to keep such a notice in a dated folder and pencil on it the day the result became public. The distance between the two dates is often the hardest sentence in the eventual story.

The arithmetic of the interval

The race was on 30 August 2026. The sample was taken before it, in Kenya. The suspension was announced after it.

What happened inside that interval is the least-reported part of any doping case. The Sydney title stood. The 2:18:31 stood. The margin of more than three minutes stood. The name stood at the top of the seventh major's roll of honour. No public document carried an asterisk.

An interval is not an accusation. An interval is a measurable thing. Stack those intervals across years and the pattern that emerges belongs to the process, not the person: sample first, result later, and in between the sport keeps running because nothing can be stopped until a laboratory's paperwork is complete.

This is where I go back to an old file, not to force an analogy but to show the method. In 2026 I filed an information request with India's National Anti-Doping Agency. The reply gave me the numbers I still quote: 312 tests on Indian track and field athletes in 2026, 84 in 2026. Of the 38 names on the national camp roster at Patiala, 14 had not been tested once in the twelve months to December 2026.

Between March 2026 and October 2026, the testing record simply stops. No explanation, no note — just blank months. I published the hole as a document in itself. The same method applies here. The question in this case is not why a test happened. One did, and it caught something. The question is how many out-of-competition tests a 33-year-old marathon runner received that year, and how many of them were sent for EPO analysis specifically.

Testing is also a budget line

This is where doping coverage usually turns emotional and my work begins. EPO screening is a separate laboratory analysis with a separate cost. In any national agency's budget it is a line item — EPO testing, or blood analysis — and the number against that line determines how many needles went into how many arms that year.

I have been requesting quarterly SAI ledgers since 2026, and the habit taught me something every sports reporter should learn: the ledger does not lie, but it does keep quiet about 78 percent of the budget. The ledger I obtained before Tokyo showed Rs 1.2 crore spent on foreign biomechanics camps for three javelin throwers, while the remaining 28 Olympic-bound athletes shared Rs 40 lakh. I printed the table because a table speaks without help.

The doping-control budget deserves the same reading. A country with a thin line against EPO testing will record a low EPO detection rate, whether or not EPO use there is high or low. That is arithmetic, and it is the arithmetic that quietly wrecks every "which country cheats most" argument.

Kenya: category, institutions, a date

Kenya sits in the AIU's highest testing-risk category, a fact that comes from the AIU's published testing framework rather than from any leak. The Anti-Doping Agency of Kenya, Athletics Kenya and the collection teams divide the work.

Here is a structure I keep writing and readers keep skipping. When a country is placed in a high-risk category, every positive there becomes easy to call a system failure — and it becomes equally easy to forget that the same category is where the most tests are conducted. Where more tests happen, more positives are caught. That is the most basic fact in the statistics, and the most ignored fact in doping coverage.

Jepchirchir's sample was taken in Kenya, before the race. Her name was in the testing pool, her location was on file, and a collection team used it. That part of the process worked. The part that stays invisible is the year-long calendar that decides how often anyone turns up at any given runner's door.

The seventh major and the contract question

Sydney has been a World Marathon Major since 2026. That status is not a sporting achievement; it is a commercial agreement, and every new major has to prove itself the way the first six did: elite field, television window, winning name.

That afternoon Sydney got the name it needed. Olympic gold, world gold, four major titles, and a win by more than three minutes in 2:18:31. That name now carries a provisional suspension, and the question turns to what documents an organiser holds for such a situation.

I do not have a public statement or a contract from the Sydney Marathon organisers. I will not write what they concealed, because I do not have the paper. I will write what that paper would answer if it were published: the terms of any appearance fee, the clause governing the withdrawal of a title, and who decides whether the roll of honour changes once a result is confirmed.

The question was never who won. It was who collected the sample, when, and when the notification was issued. The garland hangs on the same sheet of paper.

The part critics leave out

Two reactions are guaranteed. The first is "that country again" — not a finding but a filing habit, and one that turns a single athlete's case into a verdict on a continent, which is precisely how the institutions that own the budget escape scrutiny. The second is "EPO can't be caught anyway." That is plainly false, and it is the most-repeated sentence in this case. It was caught, and it was caught in an out-of-competition sample.

What both camps miss is the shape of the testing calendar. Testing calendars are built around races, while the most valuable window for EPO is the one with no race in it. An athlete entered in nothing appears on no start list, and the checks in that period generate no coverage. That is where the system's attention is thinnest, and it is not a conspiracy. It is ordinary budgeting and ordinary scheduling.

The second omission is the comfort of shrinking this case to one person: one name, one substance, one suspension. That framing leaves untouched the anti-doping budgets of several dozen countries whose EPO testing line has been cut year after year. In my own files, when the number of tests falls, the argument moves to the character of athletes and never to the balance sheets of agencies.

What to watch next

The next document is the B sample. After that comes the AIU's reasoned decision, and I can predict now that it will reach fewer people than the first headline did — because it arrives months later and contains no fresh sentence.

Three things I will be filing for: the Sydney Marathon organisers' contractual terms on titles and prize money; the AIU's annual testing figures for that pool with the EPO share broken out; and the out-of-competition collection calendar for Kenya in the first half of 2026. Whether or not answers arrive, the record of the asking will exist.

The credibility of the seventh major will no longer be settled by its course record. It will be settled by how much paper it can produce in a case like this, and how quickly that paper becomes public. The time of 2:18:31 stays on the books. It simply now carries a date in front of it — the date the sample was taken, before the race, in Kenya.